Skip to content

Clinical trials

Terminated Observational Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Observational Status: Terminated Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20043
20062
20073
20081
20102
20111
20131
20141
20161
20174
20181
20201
20212
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group2
Precision Therapeutics2
Vanderbilt-Ingram Cancer Center2
Abramson Cancer Center at Penn Medicine1
Alaunos Therapeutics1
AstraZeneca1
British Columbia Cancer Agency1
CureOne1
Lyell Immunopharma, Inc.1
M.D. Anderson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms27
Breast Neoplasms8
Carcinoma, Ovarian Epithelial8
Fallopian Tube Neoplasms8
Colonic Neoplasms4
Endometrial Neoplasms4
Recurrence4
Carcinoma, Non-Small-Cell Lung3
Lung Neoplasms3
Multiple Myeloma3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.